|
1
|
Wang M, Ji YQ, Song ZB, Ma XX, Zou YY and
Li XS: Knockdown of lncRNA ZFAS1 inhibits progression of
nasopharyngeal carcinoma by sponging miR-135a. Neoplasma.
66:939–945. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kong YG, Cui M, Chen SM, Xu Y, Xu Y and
Tao ZZ: LncRNA-LINC00460 facilitates nasopharyngeal carcinoma
tumorigenesis through sponging miR-149-5p to up-regulate IL6. Gene.
639:77–84. 2018. View Article : Google Scholar
|
|
3
|
Lee VH, Lam KO, Chang AT, Lam TC, Chiang
CL, So TH, Choi CW and Lee AW: Management of nasopharyngeal
carcinoma: Is adjuvant therapy needed? J Oncol Pract. 14:594–602.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bergamini A, Pisano C, Di Napoli M,
Arenare L, Della Pepa C, Tambaro R, Facchini G, Gargiulo P,
Rossetti S, Mangili G, et al: Cisplatin can be safely administered
to ovarian cancer patients with hypersensitivity to carboplatin.
Gynecol Oncol. 144:72–76. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng X, Li W and Tan G: Reversal of taxol
resistance by cisplatin in nasopharyngeal carcinoma by upregulating
thromspondin-1 expression. Anticancer Drugs. 21:381–388. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang Z, Zhao J, Xie W, Sun Q, Wang H and
Qiao B: LncRNA UCA1 promotes proliferation and cisplatin resistance
of oral squamous cell carcinoma by sunppressing miR-184 expression.
Cancer Med. 6:2897–2908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Chen F, Zhao M, Yang Z, Li J,
Zhang S, Zhang W, Ye L and Zhang X: The long noncoding RNA HULC
promotes liver cancer by increasing the expression of the HMGA2
oncogene via sequestration of the microRNA-186. J Biol Chem.
292:15395–15407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Zhang P, Zhu H, Li S, Chen X and Shi
L: Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of
gastric cancer and promotes tumorigenesis via activation of Wnt
signaling pathway. Biomed Pharmacother. 96:1103–1108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Song X, Wang X, Hu J and Jiang L:
Silencing of LncRNA HULC enhances chemotherapy induced apoptosis in
human gastric cancer. J Med Biochem. 35:137–143. 2016. View Article : Google Scholar
|
|
11
|
Cao C, Zhou S and Hu J: Long noncoding RNA
MAGI2-AS3/miR-218 5p/GDPD5/SEC61A1 axis drives cellular
proliferation and migration and confers cisplatin resistance in
nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 10:1012–1023.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu F, Tai Y and Ma J: LncRNA
NEAT1/let-7a-5p axis regulates the cisplatin resistance in
nasopharyngeal carcinoma by targeting Rsf-1 and modulating the
Ras-MAPK pathway. Cancer Biol Ther. 19:534–542. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao L, Cheng XL and Cao H: LncRNA THOR
attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells
via enhancing cells stemness. Biochimie. 152:63–72. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song H, Xu Y, Shi L, Xu T, Fan R, Cao M,
Xu W and Song J: LncRNA THOR increases the stemness of gastric
cancer cells via enhancing SOX9 mRNA stability. Biomed
Pharmacother. 108:338–346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Zhao Y, Liu L, Su H, Dong D, Wang
J, Zhang Y, Chen Q and Li C: MicroRNA-19b promotes nasopharyngeal
carcinoma more sensitive to cisplatin by suppressing KRAS. Technol
Cancer Res Treat. 17:15330338187936522018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang P, Lu X, Shi Z, Li X, Zhang Y, Zhao
S and Liu H: miR-205-5p regulates epithelial-mesenchymal transition
by targeting PTEN via PI3K/AKT signaling pathway in
cisplatin-resistant nasopharyngeal carcinoma cells. Gene.
710:103–113. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shao Q, Zhang P, Ma Y, Lu Z, Meng J, Li H,
Wang X, Chen D, Zhang M, Han Y, et al: MicroRNA-139-5p affects
cisplatin sensitivity in human nasopharyngeal carcinoma cells by
regulating the epithelial-to-mesenchymal transition. Gene.
652:48–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Zheng S, Jiang F, Ge D, Tang J, Chen H,
Yang J, Yao Y, Yan J, Qiu J, Yin Z, et al: LncRNA
SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of
osteosarcoma. Biomed Pharmacother. 112:1086952019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li FP, Lin DQ and Gao LY: LncRNA TUG1
promotes proliferation of vascular smooth muscle cell and
atherosclerosis through regulating miRNA-21/PTEN axis. Eur Rev Med
Pharmacol Sci. 22:7439–7447. 2018.PubMed/NCBI
|
|
21
|
Liu H, Deng H, Zhao Y, Li C and Liang Y:
LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor
growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin
Cancer Res. 37:2792018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma J, Yan H, Zhang J, Tan Y and Gu W:
Long-chain non-coding RNA (lncRNA) MT1JP suppresses biological
activities of lung cancer by regulating miRNA-423-3p/Bim Axis. Med
Sci Monit. 25:5114–5126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu M, Zhang Q, Tian XH, Wang JL, Niu YX
and Li G: lncRNA CCAT1 is a biomarker for the proliferation and
drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1
axis. Mol Carcinog. 58:2207–2217. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu D, Lu C, Qu X, Li P, Chen K, Shan L and
Zhu X: LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and
drug resistance via the miR-134-5p/MBTD1 axis. Aging (Albany NY).
11:8374–8385. 2019. View Article : Google Scholar
|
|
25
|
Zhuang J, Shen L, Yang L, Huang X, Lu Q,
Cui Y, Zheng X, Zhao X, Zhang D, Huang R, et al: TGFβ1 promotes
gemcitabine resistance through regulating the
LncRNA-LET/NF90/miR-145 signaling axis in bladder cancer.
Theranostics. 7:3053–3067. 2017. View Article : Google Scholar :
|
|
26
|
Li H, Huang J, Yu S and Lou Z: Long
non-coding RNA DLEU1 Up-regulates BIRC6 expression by competitively
sponging miR-381-3p to promote cisplatin resistance in
nasopharyngeal carcinoma. Onco Targets Ther. 13:2037–2045. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin FJ, Lin XD, Xu LY and Zhu SQ: Long
Noncoding RNA HOXA11-AS modulates the resistance of nasopharyngeal
carcinoma cells to cisplatin via miR-454-3p/c-Met. Mol Cells.
43:856–869. 2020.PubMed/NCBI
|
|
28
|
Kang Y, Jia Y, Wang Q, Zhao Q, Song M, Ni
R and Wang J: Long Noncoding RNA KCNQ1OT1 promotes the progression
of non-small cell lung cancer via regulating miR-204-5p/ATG3 Axis.
Onco Targets Ther. 12:10787–10797. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu X, Wang F, Fu M, Li Y and Wang L:
[ARTICLE WITHDRAWN] Long Noncoding RNA KCNQ1OT1 Accelerates the
Progression of Ovarian Cancer via MicroRNA-212-3/LCN2 Axis. Oncol
Res. 28:135–146. 2020. View Article : Google Scholar
|
|
30
|
Qiao CY, Qiao TY, Jin H, Liu LL, Zheng MD
and Wang ZL: LncRNA KCNQ1OT1 contributes to the cisplatin
resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14
axis. Eur Rev Med Pharmacol Sci. 24:200–212. 2020.PubMed/NCBI
|
|
31
|
Li Y, Li C, Li D, Yang L, Jin J and Zhang
B: lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in
colon cancer by targeting the miR-34a/ATG4B pathway. Onco Targets
Ther. 12:2649–2660. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qi X, Yu XJ, Wang XM, Song TN, Zhang J,
Guo XZ, Li GJ and Shao M: Knockdown of KCNQ1OT1 suppresses cell
invasion and sensitizes osteosarcoma cells to CDDP by upregulating
DNMT1-Mediated Kcnq1 expression. Mol Ther Nucleic Acids.
17:804–818. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang P, Chen D, Ma H and Li Y: LncRNA MEG3
enhances cisplatin sensitivity in non-small cell lung cancer by
regulating miR-21-5p/SOX7 axis. Onco Targets Ther. 10:5137–5149.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen J, Yu Y, Li H, Hu Q, Chen X, He Y,
Xue C, Ren F, Ren Z, Li J, et al: Long non-coding RNA PVT1 promotes
tumor progression by regulating the miR-143/HK2 axis in gallbladder
cancer. Mol Cancer. 18:332019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu ZZ, Tian YF, Wu H, Ouyang SY and Kuang
WL: LncRNA H19 promotes glioma angiogenesis through
miR-138/HIF-1α/VEGF axis. Neoplasma. 67:111–118. 2020. View Article : Google Scholar
|
|
36
|
Fu C, Li D, Zhang X, Liu N, Chi G and Jin
X: LncRNA PVT1 facilitates tumorigenesis and progression of glioma
via regulation of MiR-128-3p/GREM1 Axis and BMP signaling pathway.
Neurotherapeutics. 15:1139–1157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang S, Zhang G, Zheng W, Xue Q, Wei D,
Zheng Y and Yuan J: MiR-454-3p and miR-374b-5p suppress migration
and invasion of bladder cancer cells through targetting ZEB2.
Biosci Rep. 38:BSR201814362018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zuo J, Yu H, Xie P, Liu W, Wang K and Ni
H: miR-454-3p exerts tumor-suppressive functions by down-regulation
of NFATc2 in glioblastoma. Gene. 710:233–239. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao X, Li X, Zhou L, Ni J, Yan W, Ma R,
Wu J, Feng J and Chen P: LncRNA HOXA11-AS drives cisplatin
resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Cancer Sci. 109:3068–3079. 6;2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu L, Dong L, Wang Y, Liu L, Long H, Li H,
Li J, Yang X, Liu Z, Duan G, et al: Reversible regulation of SATB1
ubiquitination by USP47 and SMURF2 mediates colon cancer cell
proliferation and tumor progression. Cancer Lett. 448:40–51. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yan S, Yue Y, Wang J, Li W, Sun M, Gu C
and Zeng L: LINC00668 promotes tumorigenesis and progression
through sponging miR-188-5p and regulating USP47 in colorectal
cancer. Eur J Pharmacol. 858:1724642019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Naghavi L, Schwalbe M, Ghanem A and
Naumann M: Deubiquitinylase USP47 promotes RelA phosphorylation and
survival in gastric cancer cells. Biomedicines. 6:622018.
View Article : Google Scholar :
|
|
43
|
Cho J, Park J, Shin SC, Jang M, Kim JH,
Kim EE and Song EJ: USP47 promotes tumorigenesis by negative
regulation of p53 through deubiquitinating ribosomal protein S2.
Cancers (Basel). 12. pp. 11372020, View Article : Google Scholar
|
|
44
|
Hu L, Kolibaba H, Zhang S, Cao M, Niu H,
Mei H, Hao Y, Xu Y and Yin Q: MicroRNA-204-5p inhibits ovarian
cancer cell proliferation by down-regulating USP47. Cell
Transplant. 28(1 suppl): S51–S58. 2019. View Article : Google Scholar
|
|
45
|
Zhang B, Yin Y, Hu Y, Zhang J, Bian Z,
Song M, Hua D and Huang Z: MicroRNA-204-5p inhibits gastric cancer
cell proliferation by downregulating USP47 and RAB22A. Med Oncol.
32:3312015. View Article : Google Scholar
|
|
46
|
Zhang S, Ding L, Gao F and Fan H: Long
non-coding RNA DSCAM-AS1 upregulates USP47 expression through
sponging miR-101-3p to accelerate osteosarcoma progression. Biochem
Cell Biol. 98:600–611. 2020. View Article : Google Scholar : PubMed/NCBI
|
